Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's disease. [electronic resource]
Producer: 20040211Description: S97-100 p. digitalISSN:- 1526-632X
- Adenosine A2 Receptor Antagonists
- Animals
- Antiparkinson Agents -- adverse effects
- Clinical Trials as Topic -- statistics & numerical data
- Corpus Striatum -- cytology
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Dyskinesia, Drug-Induced -- prevention & control
- Globus Pallidus -- cytology
- Humans
- Levodopa -- adverse effects
- Mice
- Mice, Knockout
- Motor Activity -- drug effects
- Neurons -- drug effects
- Oxidopamine
- Parkinson Disease -- drug therapy
- Parkinsonian Disorders -- chemically induced
- Primates
- Purines -- therapeutic use
- Rats
- Receptor, Adenosine A2A -- metabolism
- Receptors, Dopamine D2 -- deficiency
- gamma-Aminobutyric Acid -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.